Hip arthrodesis: current indications and techniques.

Journal and index pages often block iframe embedding. This reader keeps the evidence details in Orthonotes and leaves the source page one click away.

Abstract

[Indexed for MEDLINE] 14. J Bone Joint Surg Am. 2025 Feb 19;107(4):356-363. doi: 10.2106/JBJS.24.00132. Epub 2024 Dec 23. Outcomes Following Direct Anterior Approach Total Hip Arthroplasty: A Contemporary Multicenter Study. Wilson JM(1), Hadley ML(2), Larson D(3), Ledford CK(4), Bingham JS(5), Wyles CC(2), Taunton MJ(2). Author information: (1)Department of Orthopedic Surgery, Emory University, Atlanta, Georgia. (2)Department of Orthopedic Surgery, Mayo Clinic, Rochester, Minnesota. (3)Department of Clinical Trials and Biostatistics, Mayo Clinic, Rochester, Minnesota. (4)Department of Orthopedic Surgery, Mayo Clinic, Jacksonville, Florida. (5)Department of Orthopedic Surgery, Mayo Clinic, Phoenix, Arizona. BACKGROUND: The direct anterior approach (DAA) is a popular approach for primary total hip arthroplasty (THA). However, the contemporary outcomes for DAA THA need further elucidation. Therefore, we aimed to describe implant survivorship, complications, and clinical outcomes after DAA THA. METHODS: From our multi-institutional total joint registry, 3,184 patients who had undergone 3,698 primary DAA THA between 2010 and 2019 were identified. The identified patients had a mean age of 65 years and a mean body mass index (BMI) of 29 kg/m 2 , and 53% of patients were female. The indications for revision and reoperation and the incidence of complications were collected and analyzed. Potential risk factors, including age, sex, BMI, and high-volume compared with low-volume operating surgeons, were examined. Descriptive statistics and Kaplan-Meier survivorship with Cox regression analyses were performed. RESULTS: At 10 years following primary DAA THA, the cohort had 96% (95% confidence interval [CI], 95% to 98%) survivorship free of any revision and 94% (95% CI, 92% to 96%) survivorship free of any reoperation. The leading indications for revision were periprosthetic joint infection (PJI) (n = 24; 5-year cumulative incidence, 0.93% [95% CI, 0.6% to 1.5%]), periprosthetic fracture (n = 20; 5-year cumulative incidence, 0.62% [95% CI, 0.4% to 1.0%]), and aseptic loosening (n = 14; 11 femoral, 3 acetabular; 5-year cumulative incidence, 0.84% [95% CI, 0.5% to 1.5%]). A BMI of ≥40 kg/m 2 was found to be significantly associated with PJI (hazard ratio [HR], 6.4; p < 0.001), reoperation (HR, 3.5; p < 0.001), and nonoperative complications (HR, 2.3; p = 0.018). Survivorship free of recurrent instability was 99.6% (95% CI, 99.4% to 99.8%) at 5 and 10 years, and the cumulative incidence of revision for instability was 0.14% at 5 years. CONCLUSIONS: In one of the largest published series to date, survivorship following DAA THA was satisfactory at early to intermediate follow-up. The leading indications for revision were PJI, periprosthetic fracture, and aseptic loosening. Instability after DAA THA was uncommon and infrequently led to revision. As a note of caution, a BMI of ≥40 kg/m 2 was identified as a risk factor for adverse outcome after DAA THA. LEVEL OF EVIDENCE: Therapeutic Level IV . See Instructions for Authors for a complete description of levels of evidence. Copyright © 2024 by The Journal of Bone and Joint Surgery, Incorporated. DOI: 10.2106/JBJS.24.00132